Bimzelx (Bimekizumbkzx)

Bimzelx (bimekizumab-bkzx) is a humanized interleukin-17A and F antagonist used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Recommended Dosage: The recommended dosage is 320 mg (given as 2 subcutaneous injections of 160 mg each) at Weeks 0, 4, 8, 12, and 16, then every eight weeks thereafter. For those weighing ≥ 120 kg, consider a dosage of 320 mg every 4 weeks after Week 16.

In case a dose is missed, administer the dose as promptly as possible. Thereafter, resume Bimzelx dosing at the regularly scheduled time.

• Bimzelx 160 mg/mL injection may increase the risk of infections. Avoid initiating treatment in all those with any clinically important active infection until the infection resolves or is adequately treated. Patients should seek medical advice in case signs or symptoms of clinically important infection occur. If a patient develops such an infection or is not responding to standard therapy, monitor them closely and discontinue treatment until the infection resolves. 
  
• Evaluate patients for tuberculosis (TB) infection before initiating this treatment. Avoid the use of this medicine in those with active TB infection. Start treatment of latent TB before administering Bimzelx. Consider anti-TB therapy prior to initiation of treatment. Closely monitor patients for signs and symptoms of active TB throughout and after treatment.
  
• Treatment with Bimekizumab-bkzx is linked with increased incidence of liver enzyme elevations. Test liver enzymes, alkaline phosphatase, and bilirubin at baseline, periodically during treatment, and as per the routine patient management. If treatment-related increases in liver enzymes develop and drug-induced liver injury is suspected, interrupt therapy until a diagnosis of liver injury is excluded. Permanently stop therapy in patients with causally associated combined elevations of transaminases and bilirubin. Those with acute liver disease or cirrhosis may be at higher risk for serious hepatic injury; avoid the use of this medicine in these patients. 
  
• Cases of inflammatory bowel disease (IBD) may develop in patients treated with IL-17 inhibitors, including Bimekizumab-bkzx 160 mg/mL. Avoid the use of this medicine in patients with active IBD. During treatment, monitor patients for signs and symptoms of IBD and stop treatment in case a new onset or worsening of signs and symptoms occurs.  
  
• Before initiating therapy with Bimzelx injection, complete all age-appropriate vaccinations as per the current immunization guidelines. Do not use live vaccines in patients treated with this therapeutic drug. Limited data exist regarding the coadministration of this drug with non-live vaccines.

What documents are required to import BIMZELX to India?

BIMZELX (bimekizumab-bkzx) injections can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
• Import permit if applicable

Is BIMZELX available in India?

BIMZELX (bimekizumab-bkzx injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Bimzelx in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

BIMZELX can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Goa, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of BIMZELX (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Bimzelx 160 mg/mL price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the BIMZELX (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Bimzelx®?

Bimekizumab-bkzx is a Generic Name for the trade name drug Bimzelx®.

What is the Manufacturer’s Name of Bimzelx®?

Bimzelx® is manufactured by UCB, Inc.

Is Bimzelx® approved by the FDA?

Yes, Bimzelx® is approved by the FDA. Date of first approval: October 17, 2023.

What is the dosage and form of Bimzelx® supplied?

Bimzelx® is supplied as injections: 160 mg/mL in a single-dose prefilled syringe or single-dose prefilled autoinjector for subcutaneous use. 

What are the most common side effects of Bimzelx®? 

The most common side effects of Bimzelx® are oral candidiasis, headache, injection site reactions, tinea infections, upper respiratory tract infections, gastroenteritis, Herpes simplex infections, folliculitis, other candida infections, acne, and fatigue. 

How much does Bimzelx® cost in India?

The cost of Bimzelx 160 mg/mL in India can vary. To procure this medication legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Bimzelx®?

Store cartons with Bimzelx® refrigerated between 2-8°C (36-46°F). Keep the medicine in the original carton to protect it from light until the time of use. Avoid freezing it.

Is it safe to buy Bimzelx® online in India?

Yes, one can buy Bimzelx online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Bimzelx® through legal channels.